First Ascent Biomedical's Functional Precision Oncology bridges that gap by testing living tumor cells to generate actionable data in about 10 days, helping physicians choose the right treatment ...
Biomarkers are redefining how oncology trials are designed, shifting from single-mutation targeting to comprehensive genomic ...
He could soon join a group of 10 others across the globe who achieved the milestone after a stem cell transplant ...
A recently published study from Fred Hutch Cancer Center dramatically expands the number of FDA-approved cancer drugs ...
Tracking how blood cancers develop over time has uncovered important genetic differences between patients whose disease stays ...
The US Food and Drug Administration on Thursday approved the first gene therapy for inherited hearing loss, a one-time ...
Researchers uncover how mutant lung cells reshape surrounding tissue through signaling loops with fibroblasts and immune ...
The investigational KRAS G12D inhibitor zoldonrasib showed evidence of clinical activity and a favorable safety profile in ...
Liquid biopsy enables genomic profiling in prostate cancer with high success rates. Learn more about its potential as a ...
Medically integrated dispensing improves affordability, adherence, and toxicity management via embedded pharmacy teams, ...
Purpose: To present the rapid-ACCE model and report our early experience of using the ACCE structure to guide systematic reviews for the rapid evaluation of emerging genetic tests. Methods: A ...
Israeli researchers find war stress is driving worse sleep, diet, exercise, and screen habits in adults and children alike.